ReVision Implant launches 2026 human trial

Belgium-based ReVision Implant launches its first human clinical test for an occipital cortex chip in October 2026. This approach wirelessly transfers power and image data to bypass retinal damage, aiming to help patients with optic nerve conditions. While earlier retinal implants failed or ceased operations, this cortical method offers a new path for artificial vision restoration.